CatalystAlert

Search CatalystAlert

Search for companies, drugs, and catalysts

Search CatalystAlert

Search for companies, drugs, and catalysts

yahoo_finance
Original article

Opus Genetics, Inc. (IRD) Reports Q2 Loss, Lags Revenue Estimates

EarningsNegative
AI Analysis

Summary

Opus Genetics reported a Q2 loss and missed revenue estimates. The company's financial performance fell short of expectations.

Importance:2/10
Sentiment:
-0.50
earningsQ2revenue missloss
Related Companies

Read the original article

Published by yahoo_finance on August 6, 2026 12:20 PM

Read Original